Kakuta, Yoichi http://orcid.org/0000-0002-7042-009X
,
Kawai, Yosuke
Okamoto, Daisuke
Takagawa, Tetsuya
Ikeya, Kentaro
Sakuraba, Hirotake
Nishida, Atsushi
Nakagawa, Shoko
Miura, Miki
Toyonaga, Takahiko
Onodera, Kei
Shinozaki, Masaru
Ishiguro, Yoh
Mizuno, Shinta
Takahara, Masahiro
Yanai, Shunichi
Hokari, Ryota
Nakagawa, Tomoo
Araki, Hiroshi
Motoya, Satoshi
Naito, Takeo
Moroi, Rintaro
Shiga, Hisashi
Endo, Katsuya
Kobayashi, Taku
Naganuma, Makoto
Hiraoka, Sakiko
Matsumoto, Takayuki
Nakamura, Shiro
Nakase, Hiroshi
Hisamatsu, Tadakazu
Sasaki, Makoto
Hanai, Hiroyuki
Andoh, Akira
Nagasaki, Masao
Kinouchi, Yoshitaka
Shimosegawa, Tooru
Masamune, Atsushi
Suzuki, Yasuo
Funding for this research was provided by:
Japan Agency for Medical Research and Development (18kk0305002, 16km0405205h0101)
Article History
Received: 12 June 2018
Accepted: 13 June 2018
First Online: 19 June 2018
Compliance with ethical standards
:
: Ryota Hokari received commercial research funding from EA pharma Co. Ltd and Chugai pharma Co. Ltd; Taku Kobayashi received lecture fees from Mitsubishi Tanabe Pharma Corporation, AbbVie Inc., Takeda Pharmaceutical Co. Ltd, and Janssen Pharmaceutical K.K.; Makoto Naganuma received commercial research funding from Mochida Pharmaceuticals Co. Ltd; Masaru Shinozaki received research grants from Mitsubishi Tanabe Pharma Co., Ltd; Shiro Nakamura received a commercial research funding from AbbVie Inc., Kyorin Pharmaceutical Co. Ltd, Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Asahi Kasei Medical Co. Ltd, Ajinomoto Pharmaceuticals Co. Ltd, Eisai Co. Ltd, JIMRO Co. Ltd, Otsuka Pharmaceutical Co. Ltd, Otsuka Pharmaceutical Factory Inc., UCB Japan Co. Ltd, and Zeria Pharmaceutical Co. Ltd; Hiroshi Nakase received lecture fees from Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceuticals Co. Ltd, and Janssen Pharmaceutical K.K., and received commercial research funding from Hoya group Pentax Medical, Boehringer Ingelheim GmbH, and Daiichi-Sankyo Co. Ltd; Tadakazu Hisamatsu received lecture fees from EA pharma Co. Ltd, AbbVie GK, Celgene K.K., Janssen Pharmaceutical K.K., Pfizer Inc., Mitsubishi Tanabe Pharma Corporation, Kyorin Pharmaceutical Co. Ltd, JIMRO Co. Mochida Pharmaceutical Co., Ltd Nichi-Iko Pharmaceutical Co., Ltd, and received commercial research funding from Mitsubishi Tanabe Pharma Corporation, EA pharma Co. Ltd, AbbVie GK, Daiichi-Sankyo, Kyorin Pharmaceutical Co. Ltd, Takeda Pharmaceutical Co. Ltd, Pfizer Inc., Mochida Pharmaceutical Co., Ltd; Masao Nagasaki held the concurrent post at Department of Cohort Genome Information Analysis endowed by Toshiba Corporation until March 2017, and received a research funding from Toshiba Corporation until March 2017; Yasuo Suzuki received lecture fees from AbbVie Inc., Kyorin Pharmaceutical Co. Ltd, Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd, Mochida Pharmaceuticals Co. Ltd, and Zeria Pharmaceutical Co. Ltd; and received commercial research funding from AbbVie Inc., Mitsubishi Tanabe Pharma Corporation, EA Pharma Co. Ltd, JIMRO Co. Ltd, Mochida Pharmaceuticals Co. Ltd, and NIPPON KAYAKU Co. Ltd.